Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen and Pseudoephedrine for Nocturnal Enuresis
NCT00240812Phase 2Completed
- Sponsor
- Johnson & Johnson
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ibuprofen, pseudoephedrine in nocturnal enuresis (NE), sponsored by Johnson & Johnson. Status: completed.
02
Drugs
ibuprofenpseudoephedrine
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT00240812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240812.